Overview

Gentamicin Bladder Instillation in Individuals With Spinal Cord Injury Having Chronic Urinary Tract Infections

Status:
Active, not recruiting

Trial end date:
2022-01-16

Target enrollment:

Participant gender:

Summary

Participants will undergo daily gentamicin bladder instillations to determine if its use will reduce the rate of symptomatic urinary tract infections (UTIs) as well as the use of oral and intravenous antibiotics in adults with chronic spinal cord injury (SCI) who have recurrent UTIs. Participants are randomized into one of three groups: 1) Gentamicin and saline instillation 2) Saline only instillation 3) Standard of care, no instillation.

Phase:

Phase 2

Details

Lead Sponsor:

University of Louisville

Treatments:

Gentamicins
Pharmaceutical Solutions